New year, new job? View the vacancies! More ...
MT-Messtechnik HJM C-Tec PMS



All publications from Paul Scherrer Institut

Giacomo Sala is an experimental physicist in the PSI Center for Neutron and Muon Science. For his project Q-GEOMSPIN, he has been awarded funding from the EU: a European Research Council (ERC) Starting Grant. © Paul Scherrer Institute PSI/Markus Fischer
  • Science

Giacomo Sala is combining two previously separate disciplines of physics: the established field of spintronics and the emerging field of quantum geometry. His Q-GEOMSPIN project at the Paul Scherrer Institute PSI could pave the way for more efficient data storage – and is now being funded with approximately CHF 2.2 million by the European Research Council (ERC).

Spintronics plus quantum: PSI researcher receives major grant

– PSI physicist Giacomo Sala receives approximately CHF 2.2 million from the European Research Council (ERC).
– In the Q-GEOMSPIN project, he is bringing together two research areas that up to now have largely been studied separately.
– This fundamental research could lead to more energy-efficient dat…

Susanne Geistlich, Head of the Clinical Drug Supply at PSI, working at one of the filling systems in the new pharmaceutical laboratory. In such cells, the radiopharmaceuticals are filled into injection vials. The aseptic environment and a special filter system ensure a sterile product. (Photo: Paul Scherrer Institute/Mahir Dzambegovic) Susanne Geistlich checks a hygiene-monitoring sample for sterility. The aseptic production of sterile medicines demands effective hygienic measures in the rooms and among the staff. (Photo: Paul Scherrer Institute/Mahir Dzambegovic)
  • New building

The new pharmaceutical laboratory for the manufacture of radiopharmaceuticals at PSI is ready for production. With its three state-of-the-art production units, novel and innovative drugs can be brought rapidly into clinical use.

Swissmedic grants operating licence for new radiopharmaceutical production facility

At PSI, with the help of a new facility, small batches of highly specific drugs will be produced in future. These will be delivered directly to hospitals for use in treating tumour patients.

For more than 20 years, in collaboration with ETH Zurich, PSI researchers have been developing new drugs for t…

Better informed: With YEARBOOK, NEWSLETTER, NEWSFLASH, NEWSEXTRA and EXPERT DIRECTORY

Stay up to date and subscribe to our monthly eMail-NEWSLETTER and our NEWSFLASH and NEWSEXTRA. Get additional information about what is happening in the world of cleanrooms with our printed YEARBOOK. And find out who the cleanroom EXPERTS are with our directory.

Berner International GmbH Systec & Solutions GmbH Piepenbrock Hydroflex